ARTICLE | Company News
BioMarin exercises Vibriolysin option
January 11, 2001 8:00 AM UTC
BioMarin (BMRN; SWX:BMRN) exercised a 1998 option to acquire an exclusive worldwide license from W.R. Grace (GRA) to Vibriolysin, an enzyme that is in preclinical testing for debridement of burns and ...